#1 Startup Dataset
Growth rates, revenue data, direct competitors and contact details.
Steven Ramael Email
Medical Director . Syndesi Therapeutics
Louvain-la-Neuve,
Locations************@syndesitherapeutics.com
Primary EmailHow to contact Steven Ramael
Join and see Steven's contact info for free!Current Roles
Employees:
20Revenue:
$3.1MAbout
Syndesi Therapeutics is developing molecules that uniquely modulate the synaptic vesicle protein SV2A, which plays a central role in synaptic transmission (the communication between neurons in the brain). Regulating synaptic transmission represents a promising approach to treating Alzheimer's Disease and other disorders with cognitive impairment. Syndesi has an exclusive license to its platform technology from UCB, the leading company in SV2A research.Syndesi Therapeutics Address
Louvain-la-Neuve, null